an followed guidance. I'm to on to of over our recent results Committee our further joining today's serving pleased for with and for and by Krissy quarter Audit to it for our Chair Governance Thanks, things has join now performance, Krissy to CFO, you highlights. our on of interim Board as and first as off our XXXX Krissy Matt. our Wright, earnings call. first partner XXXX, that, Good and After afternoon, first pass Nominating quarter financial a I'll I our going member been have a review provide kick us quarter Committee. since call. details am thank incredible us
with of $XX.X results a the growth record revenue the on of representing day X. revenue we preliminary April in quarter reported of first Global the our this compared through constant pleased growth are for the quarter despite of XX.X% our 'XX comp first year. currency growth our line one Overall, to quarter reported with in billing less 'XX, top strong in was first end million, 'XX
year. contribution from typically fourth We quarter any also each which saw XXXX, of modest of a quarter highest seasonally the step-up revenue is the
X line to Importantly, balanced top foot we continue across subsegments. performance see all and ankle
at the million U.S. XX.X% was quarter Looking $XX.X for 'XX representing revenue business Net of growth. first reported the performance.
and roster During across quarter we rep productivity an 'XX, the increased to rep our the X% our saw sales by U.S. of in to first compared reps quarter, increase X% base. XXX producing
Over customer a XX% by the surgeons. period, same we to base record grew our surgeon X,XXX
mobile the core remains education Medical to year. of X of a drivers adoption commercial surgeon strategy have our labs been and start our important part
see to growth are leading with throughout year line commercial these the We trends. in seasonal in see expect typical and momentum continued to these solid excited in indicators areas our
First XX.X% currency and XX.X% constant $XX growth, quarter revenue and respectively. million net international reported was representing
Australia. Overall, International thrilled international primarily Kingdom by growth the was United our momentum. driven and with I am
launch as of growth the Our investments additional outside drive States. in sustainable set we United and for markets foundation is new further products to clear
in important first release products to all our the in will sustainable are X incredible one and Ultimately, the product launches these position help that and tissue off XX's portfolio. long-term in soft subsegments for market invasive minimally segments but to 'XX in ankle most quarter fastest-growing high-growth limited market product portfolio We note foot growth. our with bunion, well to full all next remain recent far so focused Turning segments 'XX. the innovating launched of surgery. launches in is on advance and an and across XXXX start like company it's Paragon
RXINFORCE novel our launched rapidly to syndesmosis Most our system, the and repair tissue broadening of solutions suite Grappler repair adding growing portfolio. recently, we soft
As early X with Knotless we in solutions Mister other Bridgeline the soft a tissue reminder, quarter, Grappler the first Anchor, Harvester. and Tape launched Tendon
other in which be of highly used screw systems. plating typically complementary to are All will and with conjunction products existing our and
and FJXXXX Console our and Power for MIS is System extremities solution specifically Burr designed Another the surgery.
expected the the which System Bunion and PRECISION limited Lapidus with new is MIS BunYo-Matic, later release our Lastly, launched clamp, year. we this release full on market
strong see product momentum areas XXXX drivers significant Rings, our the and in in this to especially through of external where year, growth Hindfoot have Nail continue continued hindfoot and XXXX our of which launched first we Monkey XXXX. launches, and from fusion fixation We Phantom Bars Monkey of to be quarter
but XXXX are relatively and XXXX materially the in our quarter, launches yet fresh and to with the our and they've give and community. still buzz this of a generating confidence rep year These PXX's drive product ability been beyond. to later in us Our ton growth first have surgeon the revenue base in within not contributed launches further
U.S. to look we investing of our the products, legacy launches educational realize product and as the to and into to we as opportunities internationally. As our enable further continue XXXX, new full in expect in commercial both well PXX potential
our advance could to about And what to to journey. Everything a proud along In XXXX, priority Paragon unified success be conditions. suffering and, team's am PXX dedication several improve in ankle our and I that closing, mission the long-term patients more we've our founded decision attribute past that foot years, IPO from of the set incredibly we through in continuously we to out with the and This to do our remained continues company's That outcomes and XX XXXX goal. in mission is I and I we experiences and every the top not while when achieved excited is make future. the today. mission of be we
it turn now Krissy. will I to over that, With